Registration - In-house Corporation

Teva Canada Limited / Teva Canada Limitee / Fabien Paquette, General Manager

Registration Information

In-house Corporation name: Teva Canada Limited / Teva Canada Limitee
Previous in-house corporation names
Responsible Officer Name: Fabien Paquette, General Manager
Responsible Officer Change History
Initial registration start date: 2009-01-13
Registration status: Active
Registration Number: 958840-235321

Associated Communications

Total Number of Communication Reports: 100

Monthly communication reports in the last 6 months: 0

Version 37 of 40 (2024-07-18 to 2024-07-29)

Registration versions:

Version 37 of 40 (2024-07-18 to 2024-07-29)

Lobbying Information

Subject Matter Details

Details Regarding the Identified Subject Matter
Subject matters	Details	Categories
Intellectual Property	International Trade regarding intellectual property provisions in bilateral and multilateral trade agreements.	Policies or Program

Communication Techniques

Written communication
Oral communication

Government Institutions

Global Affairs Canada (GAC)
Health Canada (HC)

In-house Corporation Details

Description of activities

PHARMACEUTICAL COMPANY Manufacturing and commercialization of generic and over-the-counter products, as well as marketing of biosimilars and specialty medicines.

Responsible officer name and position during the period of this registration

Michael Sine, General Manager

Government funding

No government funding was received during the last completed financial year.

In-house Corporation Contact Information

Address:
30 Novopharm Court
Toronto, ON M1B 2K9
Canada

Telephone number: 416-291-8876

Parent Company Information

Teva
- 5 Basel St.
  Petach Tikva 49131
  Israel

Subsidiary Beneficiary Information

Teva Canada Limited / Teva Canada Limitee does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyists Details

Senior Officers whose lobbying activities represent less than 20% of their Duties

Benjamin Gray, VP & General Counsel | No public offices held
Michael Sine, General Manager | No public offices held

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

No lobbyists added

Teva Canada Limited/Teva Canada Limitee

The following names have been used on or after July 2, 2008

Name	From	To
Teva Canada Limited/Teva Canada Limitee	2010-11-15	current
Teva Novopharm	2009-01-13	2009-09-03

Teva Canada Limited / Teva Canada Limitee

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)
Fabien Paquette	2024-07-29	Current
Michael Sine	2022-07-26	2024-07-29
Christine Poulin	2018-04-01	2022-07-26
Douglas Sommerville	2014-01-01	2018-04-01
Barry Fishman	2009-01-13	2014-01-01

Date Modified:: 2026-05-11

Search and menus

Language selection

Registration - In-house Corporation

Teva Canada Limited / Teva Canada Limitee / Fabien Paquette, General Manager

Registration Information

Associated Communications

Version 37 of 40 (2024-07-18 to 2024-07-29)

Version 37 of 40 (2024-07-18 to 2024-07-29)

Subject Matter Details

Communication Techniques

Government Institutions

Description of activities

Responsible officer name and position during the period of this registration

Government funding

In-house Corporation Contact Information

Parent Company Information

Subsidiary Beneficiary Information

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties